Oklahoma City, OK – January 5, 2006 – American Health Partners (AHP) announced Wednesday, January 5, that two former Cardinal Health executives have joined the Oklahoma City based health products marketing and distribution management firm.

“We are excited to have Brad Adams joining us as Director of Client Services and David Dobbs on board as Director of Business Development,” said Brian Banks, president of American Health Partners. “Our clients will benefit from their tremendous health-care experience and industry knowledge.”

Prior to joining American Health Partners, Brad Adams was an industry leader with Cardinal Health, a $75 billion, global company serving the health-care industry with a broad portfolio of products and services. Adams’ expertise in the field earned him the status of Regional Manager of the Year for Cardinal Scientific Products on numerous occasions.

“I have a strong appreciation for the difference health-care innovations can make in the lives of people,” Adams said. “Bringing innovations to life is what American Health Partners does best. I have spent 20 years in the industry and look forward to utilizing my experiences to help innovative health-care professionals bring their product from concept to commerce.”

As a former Cardinal Health industry leader, David Dobbs brings over 13 years of professional sales and management expertise to American Health Partners. As Director of Business Development for the firm, Dobbs’ primary role is to introduce health-care innovators to American Health Partners’ market readiness and distribution management process, which is designed to maximize the market potential for innovative health products.

“I hope to utilize my understanding of distribution networks within the health-care industry to help health innovators secure quality representation in the marketplace,” said Dobbs. “Developing strong and deep relationships within the health field is a critical element to the sales and marketing success of any product. My goal is to ensure AHP’s clients are not disappointed.”

Members of the American Health Partners executive team, including Banks, Adams and Dobbs, recently returned from Dusseldorf, Germany where American Health Partners participated in Medica, the world's largest medical international trade fair. Continued interaction at the international level generated considerable interest among participants regarding AHP’s ability to bring health care innovations to reality for clients.

American Health Partners is known for bringing medical innovations to life through a proprietary MINDMODEL™ process. The AHP market readiness and distribution management system has been utilized to introduce MedMira’s Reveal™ G2 Rapid HIV-1 Antibody Test the market’s fastest FDA approved HIV test and ThyroTec’s ThyroTest™, the first ever FDA approved and CLIA Waived rapid hypothyroid diagnostic screening device.

Honey Brook, PA. – Thanks to FDA approval of ThyroTest™, a new rapid hypothyroid diagnostic screening device, detection of a common thyroid disease will now come sooner rather than later for millions of Americans. More Americans suffer from thyroid disease than diabetes and cancer combined.

Currently patients suffering from symptoms of hypothyroidism have to wait days to discover lab results. Because ThyroTest™ has also gained CLIA Waiver status; patients can now get test result for hypothyroidism in minutes, right in the doctor’s office.

“We are excited about bringing ThyroTest™ to the marketplace,” said Jim Small, president of ThyroTec, a New Jersey based medical products development company. “ThyroTest™ is the first, and only, product to receive FDA approval and CLIA Waiver for identifying above normal levels of thyroid stimulating hormone (TSH) in a rapid format.

This simple rapid diagnostic screen test is a qualitative measurement that allows physicians to screen patients for hypothyroidism in ten minutes with a whole blood sample.”

Hypothyroidism develops when the thyroid gland does not produce enough thyroid hormone, which regulates body’s metabolism. A lack of thyroid hormone affects many body systems.

The incidence of hypothyroidism tends to increase with age, with older people, especially women, at highest risk.

Common symptoms include weight gain, fatigue, mood swings, weakness, dry and coarse skin and hair, hair loss, depression, decreased libido, trouble swallowing, increased cholesterol, heavy or irregular periods or trouble getting pregnant.

An estimated 13 million Americans live undiagnosed and needlessly suffer from hypothyroidism. It is also estimated that three to five percent of the U.S. population has some form of thyroid disease. Approximately one in every eight of

American women will develop a thyroid disorder during her lifetime.

ThyroTec has chosen American Health Partners, of Oklahoma City to develop ThyroTest™ brand identity, final market preparation, selection of national sales partners, training and the management of distribution.

“American Health Partners recognizes the benefit of providing doctors a rapid screen for hypothyroidism. Millions of patients who needlessly suffer from the symptoms of hypothyroidism can be screened in one office visit and further steps for treatment can begin immediately,” said Brian Banks, president of American Health Partners. “American Health Partners brings medical innovations to life through a proprietary market readiness process and proven distribution management network. We look forward to partnering with ThyroTec on this outstanding medical innovation.”

For interviews, photography or additional information regarding ThyroTest™ please contact:

Jim Small
President/CEO,ThyroTec, Inc.
1801 Horseshoe Pike, Suite One
Honey Brook, Pa 19344
Email: info@thyrotest.com
Ph: 610-942-8971

Of interest to editors and journalists covering: Business/Finance, Medical Research, MedTech, Health, Hospitals, PA News

American Health Partners, of Oklahoma City, has been chosen by ThyroTec, a New Jersey based medical products development company, to launch a presence in the market, establish brand equity, finalize product packaging, and develop and implement all sales and distribution functions for ThyroTest™, a new FDA approved, CLIA Waived rapid hypothyroid diagnostic screening device.

“American Health Partners recognizes the benefit of providing doctors a rapid screen for hypothyroidism. Millions of patients who needlessly suffer from the symptoms of hypothyroidism can be screened in one office visit and further steps for treatment can begin immediately,” said Brian Banks, president of American Health Partners. “American Health Partners brings medical innovations to life through a proprietary market readiness process and proven distribution management network. We look forward to partnering with ThyroTec on this outstanding medical innovation.”

Currently patients suffering from symptoms of hypothyroidism have to wait days to discover lab results. Because ThyroTest™ has also gained CLIA Waiver status; patients can now get test result for hypothyroidism in minutes, right in the doctor’s office.

“We are excited about bringing ThyroTest to the marketplace,” said Jim Small, president of ThyroTec, a New Jersey based medical products development company. “ThyroTest is the first, and only, product to receive FDA approval and CLIA Waiver for identifying above normal levels of thyroid stimulating hormone (TSH) in a rapid format.

This simple rapid diagnostic screen test is a qualitative measurement that allows physicians to screen patients for hypothyroidism in ten minutes with a whole blood sample.”

Hypothyroidism develops when the thyroid gland does not produce enough thyroid hormone, which regulates body’s metabolism. A lack of thyroid hormone affects many body systems.

The incidence of hypothyroidism tends to increase with age, with older people, especially women, at highest risk.

Common symptoms include weight gain, fatigue, mood swings, weakness, dry and coarse skin and hair, hair loss, depression, decreased libido, trouble swallowing, increased cholesterol, heavy or irregular periods or trouble getting pregnant.

An estimated 13 million Americans live undiagnosed and needlessly suffer from hypothyroidism. It is also estimated that three to five percent of the U.S. population has some form of thyroid disease. Approximately one in every eight of

American women will develop a thyroid disorder during her lifetime.